Citation: Sm. Shalet et Rg. Rosenfeld, GROWTH-HORMONE REPLACEMENT THERAPY DURING TRANSITION OF PATIENTS WITHCHILDHOOD-ONSET GROWTH-HORMONE DEFICIENCY INTO ADULTHOOD - WHAT ARE THE ISSUES, Growth hormone & IGF research, 8, 1998, pp. 177-184
Authors:
TILLMANN V
SHALET SM
PRICE DA
WALES JKH
PENNELLS L
SODEN J
GILL MS
WHATMORE AJ
CLAYTON PE
Citation: V. Tillmann et al., SERUM INSULIN-LIKE GROWTH-FACTOR-I, IGF BINDING PROTEIN-3 AND IGFBP-3PROTEASE ACTIVITY AFTER CRANIAL IRRADIATION, Hormone research, 50(2), 1998, pp. 71-77
Citation: Sm. Shalet et Bmd. Brennan, GROWTH AND GROWTH-HORMONE STATUS FOLLOWING TREATMENT FOR CHILDHOOD LEUKEMIA, Hormone research, 50(1), 1998, pp. 1-10
Authors:
BRENNAN BMD
RAHIM A
MACKIE EM
EDEN OB
SHALET SM
Citation: Bmd. Brennan et al., GROWTH-HORMONE STATUS IN ADULTS TREATED FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD, Clinical endocrinology, 48(6), 1998, pp. 777-783
Authors:
TOOGOOD AA
JONES J
ONEILL PA
THORNER MO
SHALET SM
Citation: Aa. Toogood et al., THE DIAGNOSIS OF SEVERE GROWTH-HORMONE DEFICIENCY IN ELDERLY PATIENTSWITH HYPOTHALAMIC-PITUITARY DISEASE, Clinical endocrinology, 48(5), 1998, pp. 569-576
Citation: A. Rahim et al., LONG-TERM CHANGE IN THE BONE-MINERAL DENSITY OF ADULTS WITH ADULT-ONSET GROWTH-HORMONE (GH) DEFICIENCY IN RESPONSE TO SHORT OR LONG-TERM GHREPLACEMENT THERAPY, Clinical endocrinology, 48(4), 1998, pp. 463-469
Citation: Sj. Howell et al., GROWTH-HORMONE REPLACEMENT AND THE RISK OF MALIGNANCY IN CHILDREN WITH NEUROFIBROMATOSIS, The Journal of pediatrics, 133(2), 1998, pp. 201-205
Citation: Gr. Williams et al., THYROID-HORMONE ACTIONS ON CARTILAGE AND BONE - INTERACTIONS WITH OTHER HORMONES AT THE EPIPHYSEAL PLATE AND EFFECTS ON LINEAR GROWTH, Journal of Endocrinology, 157(3), 1998, pp. 391-403
Authors:
GILL MS
TOOGOOD AA
ONEILL PA
THORNER MO
SHALET SM
CLAYTON PE
Citation: Ms. Gill et al., URINARY GROWTH-HORMONE (GH), INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I), AND IGF-BINDING PROTEIN-3 MEASUREMENTS IN THE DIAGNOSIS OF ADULT GH DEFICIENCY - COMMENT, The Journal of clinical endocrinology and metabolism, 83(7), 1998, pp. 2562-2565
Citation: A. Rahim et al., GROWTH-HORMONE STATUS DURING LONG-TERM HEXARELIN THERAPY, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1644-1649
Citation: Sr. Peacey et al., HYPOTHALAMIC DYSFUNCTION IN CURED ACROMEGALY IS TREATMENT MODALITY DEPENDENT, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1682-1686
Citation: H. Robson et al., GLUCOCORTICOID MODULATION OF CYTOTOXICITY - DIFFERENCES BETWEEN THE ROS17 2.8 AND UMR106 OSTEOSARCOMA CELL-LINES/, British Journal of Cancer, 78, 1998, pp. 42-42
Citation: Sj. Howell et al., GROWTH-HORMONE REPLACEMENT IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS, Archives of Disease in Childhood, 78(5), 1998, pp. 469-473
Citation: Aa. Toogood et Sm. Shalet, DIAGNOSIS OF SEVERE GROWTH-HORMONE (GH) DEFICIENCY IN YOUNG-ADULTS WHO RECEIVED GH REPLACEMENT THERAPY DURING CHILDHOOD, Acta paediatrica, 86, 1997, pp. 117-120
Authors:
GILL MS
TOOGOOD AA
ONEILL PA
ADAMS JE
THORNER MO
SHALET SM
CLAYTON PE
Citation: Ms. Gill et al., RELATIONSHIP BETWEEN GROWTH-HORMONE (GH) STATUS, SERUM LEPTIN AND BODY-COMPOSITION IN HEALTHY AND GH DEFICIENT ELDERLY SUBJECTS, Clinical endocrinology, 47(2), 1997, pp. 161-167
Authors:
OGILVYSTUART AL
STIRLING HF
KELNAR CJH
SAVAGE MO
DUNGER DB
BUCKLER JMH
SHALET SM
Citation: Al. Ogilvystuart et al., TREATMENT OF RADIATION-INDUCED GROWTH-HORMONE DEFICIENCY WITH GROWTH HORMONE-RELEASING HORMONE, Clinical endocrinology, 46(5), 1997, pp. 571-578
Authors:
CROWNE EC
WALLACE WHB
MOORE C
MITCHELL R
ROBERTSON WH
HOLLY JMP
SHALET SM
Citation: Ec. Crowne et al., EFFECT OF LOW-DOSE OXANDROLONE AND TESTOSTERONE TREATMENT ON THE PITUITARY-TESTICULAR AND GH AXES IN BOYS WITH CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY, Clinical endocrinology, 46(2), 1997, pp. 209-216